drugset / Trial / NCT03594240

Vitamin B Complex and Diabetic Nephropathy in Type 1 Diabetes

NCT03594240

Phase 3 Completed 80 enrolled Ain Shams University
RandomizedParallel-groupTriple-blindTreatment

Summary

Homocysteine levels have been found elevated in T1DM patients with Diabetic nephropathy (DN) due to several causes, including dietary deficiencies. Hyperhomocysteinemia induces renal injury and is associated with increasing urinary albumin excretion(UAE). Therefore, the investigators performed a randomized-controlled trial of oral supplementation with vitamin B complex as an adjuvant therapy for nephropathy in pediatric patients with T1DM and assessed its relation to homocysteine levels, glycemic control, microalbuminuria and cystatin C as a marker of nephropathy.

Timeline

Start
2017-03-01
Primary completion
2018-03-01
Completion
2018-04-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Vitamin B Complex Unknown Oral